Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  KOREA EXCHANGE (KOSDAQ)  >  Medy Tox Inc    086900   KR7086900008

MEDY TOX INC

(086900)
  Report  
No quotes available
-- KRW   --.--%
SummaryNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector news
The feature you requested does not exist. However, we suggest the following feature: .
Latest news on MEDY TOX INC

- No features available -

More news
Financials (KRW)
Sales 2019 227 B
EBIT 2019 97,4 B
Net income 2019 80,7 B
Finance 2019 7,45 B
Yield 2019 0,43%
P/E ratio 2019 30,85
P/E ratio 2020 25,06
EV / Sales 2019 11,3x
EV / Sales 2020 9,30x
Capitalization 2 564 B
Chart MEDY TOX INC
Duration : Period :
Medy Tox Inc Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 13
Average target price 679 364  KRW
Spread / Average Target 54%
EPS Revisions
Managers
NameTitle
Hyun-Ho Jeong Chief Executive Officer & Director
Gi-Hyuk Yang Director & Head-Research
Tae-Cheon Jeong Outside Director
Seung-Beom Park Director & Head-Production
Young-Ik Cheon Auditor
Sector and Competitors
1st jan.Capitalization (M$)
MEDY TOX INC2 378
CSL LIMITED14.77%64 329
BIOGEN-20.54%43 310
ALEXION PHARMACEUTICALS36.00%25 574
SAMSUNG BIOLOGICS CO LTD--.--%16 821
GRIFOLS7.90%16 048